Patient safety is our highest priority. Almeda Pharmaceuticals AG continuously monitors the safety of the medicinal products for which we are responsible.

How to report
If you have experienced a side effect or any other safety concern with an Almeda Pharmaceuticals AG product, please contact our Pharmacovigilance team:

E-mail: safety@almedapharma.ch   

Almeda Pharmaceuticals AG, Pharmacovigilance, Dammstrasse 19, CH-6300 Zug, Switzerland

Reports can be submitted by patients, caregivers and healthcare professionals.

What to report

• Any suspected side effect (adverse reaction), even if you are not sure it was caused by the product
• Lack of effect
• Overdose, misuse, abuse or medication errors
• Use during pregnancy or breastfeeding
• Off-label use or accidental (occupational) exposure
• Suspected transmission of an infectious agent
• Product quality complaints and suspected falsified products, with or without a side effect

Information to include (if available)

• Patient: initials, age or date of birth, sex
• Product: name, batch number, dose, start and stop dates
• Description of the side effect: what happened, when it started, outcome
• Your contact details, so that we can ask follow-up questions if needed

Please report even if you do not have all of this information.

What happens next
We will confirm receipt of your report. Our Pharmacovigilance team will assess it and may contact you for further information. Reports are handled in line with applicable pharmacovigilance legislation and forwarded to the competent authorities where required.

Data protection
Personal data provided in a safety report are processed only for pharmacovigilance purposes, kept confidential and pseudonymised where possible, in accordance with the Swiss Federal Act on Data Protection, the EU GDPR where applicable, and our internal Policies.

Medical information
For questions about our products, please contact office@almedapharma.ch.